<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37141260</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>5</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Efficacy of home-based inspiratory muscle training in patients post-covid-19: Protocol for a randomized clinical trial.</ArticleTitle><Pagination><StartPage>e0279310</StartPage><MedlinePgn>e0279310</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0279310</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0279310</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Current evidence suggests the emergence of a novel syndrome (long COVID syndrome) due to sequels and persistent COVID-19 symptoms. Respiratory muscle training improves respiratory muscle strength, exercise capacity, diaphragm thickness, and dyspnea, especially in patients with decreased respiratory muscle strength. This study aims to evaluate the effectiveness of a protocol for home-based inspiratory muscle training to improve respiratory muscle strength, dyspnea, and quality of life of patients post-COVID-19.</AbstractText><AbstractText Label="METHODS AND ANALYSES">This randomized, controlled, double-blind clinical trial will be conducted at the Instituto de Medicina Tropical of Universidade Federal do Rio Grande do Norte (Brazil). Sample size will be determined using maximal inspiratory pressure after a pilot study with five patients per group (total of 10 patients). Patients included in the study will be evaluated in three moments: pre-training (initial), post-training (three weeks), and retention (24 weeks). The sample will be randomized in two groups: active (IMT using 30% of IMT and load increase of 10% of initial IMT every week. Patients will perform 30 repetitions, twice a day (morning and afternoon), for seven consecutive days, and six weeks) and SHAM (IMT without load). The following measurements will be assessed: anthropometry, respiratory muscle strength, pulmonary volume and capacity, dyspnea, perception of effort and lower limb fatigue, handgrip strength, functional capacity, anxiety, depression, and functional status. After initial evaluation, all patients will receive a POWERbreathe&#xae; (POWERbreathe&#xae;, HaB Ltd, Southam, UK) device to perform the training. Normality will be verified using Shapiro-Wilk or Kolmogorov-Smirnov, according to the number of patients included. Variables presenting nonparametric distribution will be compared using Wilcoxon (intragroup analysis) and Mann-Whitney test (intergroup analysis), whereas repeated measures two-way ANOVA will be performed in case of parametric distribution. Dunn's post hoc test will be used to identify significant differences in the two-way ANOVA test.</AbstractText><AbstractText Label="PRIMARY OUTCOMES">Respiratory muscle strength, dyspnea, and quality of life of post-COVID-19 patients.</AbstractText><AbstractText Label="SECOND OUTCOMES">Pulmonary function, dyspnea, exercise tolerance, handgrip strength, anxiety, depression, and functional status.</AbstractText><AbstractText Label="TRIAL REGISTRATION">Trial register number NCT05077241.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Gon&#xe7;alo Silva et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gon&#xe7;alo Silva</LastName><ForeName>Gabriely Azev&#xea;do</ForeName><Initials>GA</Initials><Identifier Source="ORCID">0000-0002-6995-1280</Identifier><AffiliationInfo><Affiliation>Postgraduate Program in Physiotherapy (PPGFIS), Laboratory of Measures and Evaluation in Health, Federal University of Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nogueira</LastName><ForeName>Ivan Daniel Bezerra</ForeName><Initials>IDB</Initials><Identifier Source="ORCID">0000-0001-8190-7656</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Federal University of Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva Chiappa</LastName><ForeName>Gaspar Rog&#xe9;rio</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>University Center of An&#xe1;polis (Evangelical University of Goi&#xe1;s), Human Movement and Rehabilitation Graduate Program, An&#xe1;polis, Goi&#xe1;s, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nogueira</LastName><ForeName>Patr&#xed;cia Ang&#xe9;lica de Miranda Silva</ForeName><Initials>PAMS</Initials><Identifier Source="ORCID">0000-0002-3763-2410</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Federal University of Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05077241</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018737" MajorTopicYN="N">Hand Strength</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001945" MajorTopicYN="N">Breathing Exercises</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003964" MajorTopicYN="N">Diaphragm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012132" MajorTopicYN="N">Respiratory Muscles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053580" MajorTopicYN="N">Muscle Strength</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017079" MajorTopicYN="N">Exercise Tolerance</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>13</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37141260</ArticleId><ArticleId IdType="pmc">PMC10159136</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0279310</ArticleId><ArticleId IdType="pii">PONE-D-22-02812</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72&#x202f;314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020. Apr 7;323(13):1239&#x2013;1242.</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020. Mar 28;395(10229):1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YC, Lee PI, Hsueh PR. Evolving reporting criteria of COVID-19 in Taiwan during the epidemic. J Microbiol Immunol Infect. 2020. Jun;53(3):413&#x2013;418. doi: 10.1016/j.jmii.2020.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.03.014</ArticleId><ArticleId IdType="pmc">PMC7267588</ArticleId><ArticleId IdType="pubmed">32224117</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CC, Ko WC, Lee PI, Jean SS, Hsueh PR. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents. 2020. Aug;56(2):106024. doi: 10.1016/j.ijantimicag.2020.106024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106024</ArticleId><ArticleId IdType="pmc">PMC7243791</ArticleId><ArticleId IdType="pubmed">32450197</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020. Aug 11;324(6):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasarmidi E, Tsitoura E, Spandidos DA, Tzanakis N, Antoniou KM. Pulmonary fibrosis in the aftermath of the COVID-19 era (Review). Exp Ther Med. 2020. Sep;20(3):2557&#x2013;2560. doi: 10.3892/etm.2020.8980</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2020.8980</ArticleId><ArticleId IdType="pmc">PMC7401793</ArticleId><ArticleId IdType="pubmed">32765748</ArticleId></ArticleIdList></Reference><Reference><Citation>Severin R, Arena R, Lavie CJ, Bond S, Phillips SA. Respiratory Muscle Performance Screening for Infectious Disease Management Following COVID-19: A Highly Pressurized Situation. Am J Med. 2020. Sep;133(9):1025&#x2013;1032. doi: 10.1016/j.amjmed.2020.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2020.04.003</ArticleId><ArticleId IdType="pmc">PMC7182755</ArticleId><ArticleId IdType="pubmed">32343947</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohmwald K, G&#xe1;lvez NMS, R&#xed;os M, Kalergis AM. Neurologic Alterations Due to Respiratory Virus Infections. Front Cell Neurosci. 2018. Oct 26;12: 386. doi: 10.3389/fncel.2018.00386</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00386</ArticleId><ArticleId IdType="pmc">PMC6212673</ArticleId><ArticleId IdType="pubmed">30416428</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al.. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020. Jul;87:18&#x2013;22. doi: 10.1016/j.bbi.2020.03.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, et al.. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020. Oct;89:594&#x2013;600. doi: 10.1016/j.bbi.2020.07.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker-Davies RM, O&#x2019;Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, et al.. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020. Aug;54(16):949&#x2013;959. doi: 10.1136/bjsports-2020-102596</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2020-102596</ArticleId><ArticleId IdType="pmc">PMC7418628</ArticleId><ArticleId IdType="pubmed">32475821</ArticleId></ArticleIdList></Reference><Reference><Citation>Abodonya AM, Abdelbasset WK, Awad EA, Elalfy IE, Salem HA, Elsayed SH. Inspiratory muscle training for recovered COVID-19 patients after weaning from mechanical ventilation: A pilot control clinical study. Medicine (Baltimore). 2021. Apr 2;100(13):e25339. doi: 10.1097/MD.0000000000025339</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000025339</ArticleId><ArticleId IdType="pmc">PMC8021337</ArticleId><ArticleId IdType="pubmed">33787632</ArticleId></ArticleIdList></Reference><Reference><Citation>McNarry MA, Berg RMG, Shelley J, Hudson J, Saynor ZL, Duckers J, et al.. Inspiratory Muscle Training Enhances Recovery Post COVID-19: A Randomised Controlled Trial. Eur Respir J. 2022. Mar 2:2103101. doi: 10.1183/13993003.03101-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03101-2021</ArticleId><ArticleId IdType="pmc">PMC8900538</ArticleId><ArticleId IdType="pubmed">35236727</ArticleId></ArticleIdList></Reference><Reference><Citation>Neder JA, Andreoni S, Lerario MC, Nery LE. Reference values for lung function tests. II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res. 1999. Jun;32(6):719&#x2013;27. doi: 10.1590/s0100-879x1999000600007</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0100-879x1999000600007</ArticleId><ArticleId IdType="pubmed">10412550</ArticleId></ArticleIdList></Reference><Reference><Citation>raham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al.. Standardization of Spirometry 2019. Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70&#x2013;e88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6794117</ArticleId><ArticleId IdType="pubmed">31613151</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira CA, Sato T, Rodrigues SC. New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol. 2007. Jul-Aug;33(4):397&#x2013;406. doi: 10.1590/s1806-37132007000400008</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s1806-37132007000400008</ArticleId><ArticleId IdType="pubmed">17982531</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999. Jul;54(7):581&#x2013;6. doi: 10.1136/thx.54.7.581</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.54.7.581</ArticleId><ArticleId IdType="pmc">PMC1745516</ArticleId><ArticleId IdType="pubmed">10377201</ArticleId></ArticleIdList></Reference><Reference><Citation>Novaes RD et al.. Equa&#xe7;&#xf5;es de refer&#xea;ncia para a predi&#xe7;&#xe3;o da for&#xe7;a de preens&#xe3;o manual em brasileiros de meia idade e idosos. Fisiot Pesq. 2009; 16 (3):217&#x2013;222.</Citation></Reference><Reference><Citation>Marucci MFN et al.. Estado nutricional e capacidade f&#xed;sica. O Projeto SABE no Munic&#xed;pio de S&#xe3;o Paulo: uma abordagem inicial. Bras&#xed;lia: OPAS/MS. 2003: 95&#x2013;117.</Citation></Reference><Reference><Citation>Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al.. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014. Dec;44(6):1428&#x2013;46. doi: 10.1183/09031936.00150314</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00150314</ArticleId><ArticleId IdType="pubmed">25359355</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975. Nov;12(3):189&#x2013;98. doi: 10.1016/0022-3956(75)90026-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3956(75)90026-6</ArticleId><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertolucci PH, Brucki S, Campacci SR, Juliano Y. O mini-exame do estado mental em uma popula&#xe7;&#xe3;o geral: impacto da escolaridade. Arqu de Neuro-psiquiatria. 1994;52(1): 01&#x2013;07.</Citation><ArticleIdList><ArticleId IdType="pubmed">8002795</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraz CMB, Mein&#xe3;o I, Quaresma M.Tradu&#xe7;&#xe3;o para a l&#xed;ngua portuguesa e valida&#xe7;&#xe3;o do question&#xe1;rio gen&#xe9;rico de avalia&#xe7;&#xe3;o de qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reum. 1999;39:143&#x2013;150.</Citation></Reference><Reference><Citation>Laguardia J, Campos MR, Travassos CM, Najar AL, Anjos LA, Vasconcellos MM. Psychometric evaluation of the SF-36 (v.2) questionnaire in a probability sample of Brazilian households: results of the survey Pesquisa Dimens&#xf5;es Sociais das Desigualdades (PDSD), Brazil, 2008. Health Qual Life Outcomes. 2011. Aug 3;9:61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3162522</ArticleId><ArticleId IdType="pubmed">21812986</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992. Jun;30(6):473&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazo G Z et al.. Validade concorrente e reprodutibilidade: teste-reteste do Question&#xe1;rio de Baecke modificado para idosos. Rev Bras de Ativ F&#xed;s &amp; Saud. 2011; 6(1):5&#x2013;11.</Citation></Reference><Reference><Citation>Benedetti TB, Mazo GZ, de Barros MVG. Aplica&#xe7;&#xe3;o do question&#xe1;rio internacional de atividades f&#xed;sicas para avalia&#xe7;&#xe3;o do n&#xed;vel de atividades f&#xed;sica de mulheres idosas: Validade concorrente e reprodutibilidade teste-reteste. Rev Bras de ci&#xea;nc e mov 2008;12(1):25&#x2013;34.</Citation></Reference><Reference><Citation>Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al.. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000. Sep;32(9 Suppl):S498&#x2013;504. doi: 10.1097/00005768-200009001-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005768-200009001-00009</ArticleId><ArticleId IdType="pubmed">10993420</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsudo SM et al.. N&#xed;vel de atividade f&#xed;sica da popula&#xe7;&#xe3;o do Estado de S&#xe3;o Paulo: an&#xe1;lise de acordo com o g&#xea;nero, idade, n&#xed;vel socioecon&#xf4;mico, distribui&#xe7;&#xe3;o geogr&#xe1;fica e de conhecimento. Rev bras de ci&#xea;nc e mov, v. 10, n. 4, 2008.</Citation></Reference><Reference><Citation>Zung WW. A rating instrument for anxiety disorders. Psychosomatics. 1971. Nov-Dec;12(6):371&#x2013;9. doi: 10.1016/S0033-3182(71)71479-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0033-3182(71)71479-0</ArticleId><ArticleId IdType="pubmed">5172928</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon GJAM, Barco S, Endres M, Geelhoed JJM, Knauss S, et al.. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020. Jul 2;56(1):2001494. doi: 10.1183/13993003.01494-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado FVC, Meys R, Delbressine JM. et al.. Construct validity of the PostCOVID-19 Functional Status Scale in adult subjects with COVID-19. Health Qual Life Outcomes. 2021;19, 40. doi: 10.1186/s12955-021-01691-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-021-01691-2</ArticleId><ArticleId IdType="pmc">PMC7856622</ArticleId><ArticleId IdType="pubmed">33536042</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>